Kiran Mazumdar Shaw

Kiran Mazumdar Shaw tells BBC World News the secret behind her success

Kiran Mazumdar Shaw tells BBC World News the secret behind her success

As part of this month’s Fast Forward India season, BBC World News Business Correspondent Sameer Hashmi interviewed Kiran Mazumdar Shaw, India's first billionaire woman entrepreneur and founder of the country’s largest biopharmaceutical company Biocon. She spoke to new series India’s Game-Changers about her rise to the top, developing new drugs to treat diseases at an affordable cost and her success in a country where women find it hard to get past the first rung in business.

On the challenges of being a woman starting a business in the 1970s:

Biocon posts better-than-expected Q2 net profit

Biocon posts better-than-expected Q2 net profit Biotech giant Biocon has reported a better-than-expected second quarter net profit growth, thanks to better export realization owing to a depreciating rupee.

The Bangalore-based biotechnology company said its net profit for the second quarter through September 30 jumped 4.6 per cent to Rs 90 crore, from the corresponding period of previous year.

Total revenues jumped 19 per cent to settle at Rs 642 crore, while branded formulations business enjoyed a growth of 42 per cent to Rs 91 crore. Biopharma segment grew 8 per cent to Rs 372 crore.

Prof Wuthrich inaugurates Biocon Research Centre

Prof Wuthrich inaugurates Biocon Research CentreA new Integrated Research and Development Centre of the Indian biotechnology major, Biocon has been inaugurated by internationally renowned Nobel Laureate Prof Kurt Wuthrich.

Biocon chief Kiran Mazumdar Shaw said at the event that 300 scientists would be employed at the new Biocon Research Centre (BRC). However, she did not define the timeframe for recruiting the scientists for the centre. Shaw also said that BRC is equipped with cutting edge instrumentation for extensive molecular and functional characterisation of Biologics.

Biocon upbeat about branded formulations

Biocon upbeat about branded formulations Bangalore based biotechnology major, Biocon is optimistic about the branded formulations business, which recorded a strong growth of 37 percent in the half of the current fiscal year.

Kiran Mazumdar Shaw, chairman and managing director said "We recently launched a reusable insulin delivery device which will further propel sales in the branded formulations vertical."




Check out More news from Telecom Sector :: Pharmaceutical Sector :: Auto Sector :: Infrastructure :: Real Estate


Syndicate content